Open AccessBaricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
Author(s) -
Nancy Kierstin Reid,
Kayla Rena Joyner,
Temeka Lewis-Wolfson
Publication year - 2022
Publication title -
annals of pharmacotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.926
H-Index - 113
eISSN - 1542-6270
pISSN - 1060-0280
DOI - 10.1177/10600280221133376
Subject(s) - tocilizumab , medicine , mechanical ventilation , retrospective cohort study , clinical endpoint , surgery , randomized controlled trial , rheumatoid arthritis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom